Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “lung cancer”

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)Completed
NCT03940703Phase 2Updated Aug 21, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Non-small Cell Lung Cancer
United States, Belgium, China, France, Germany +12 more
Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung TumorsRecruiting
NCT06739031NAUpdated Aug 21, 2026
Sponsor: Energenx Medical LTD.
NSCLC
China
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)Recruiting
NCT07554339Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Brazil, China +9 more
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerActive Not Recruiting
NCT06632327Phase 3Updated Aug 21, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Resectable Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung CancerActive Not Recruiting
NCT04699123Phase 2Updated Aug 21, 2026
Sponsor: Yale University
Advanced Non-small Cell Lung Cancer
United States
Pediatric Long-Term Follow-up and Rollover StudyActive Not Recruiting
NCT03975829Phase 4Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Diffuse Astrocytoma · Anaplastic Astrocytoma · Astrocytoma · Oligodendroglioma, Childhood
United States, Argentina, Australia, Belgium, Brazil +14 more
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaRecruiting
NCT06885697Phase 1Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Mesothelioma · Neoplasms · Stomach Neoplasms · Pancreatic Neoplasms
United States
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)Recruiting
NCT07513376Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Australia, Canada, France, Germany +11 more
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialRecruiting
NCT06498635Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States
Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and SurvivorsActive Not Recruiting
NCT04447222N/AUpdated Aug 21, 2026
Sponsor: M.D. Anderson Cancer Center
COVID-19 Infection · Malignant Solid Neoplasm
United States
Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette SmokersNot Yet Recruiting
NCT07553819NAUpdated Aug 21, 2026
Sponsor: Roswell Park Cancer Institute
Lung Carcinoma
United States
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD MutationsRecruiting
NCT07195695Phase 3Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruiting
NCT07623369Phase 1Updated Aug 21, 2026
Sponsor: Huahui Health
Solid Tumor · Non-small Cell Lung Cancer · Hepatocellular Carcinoma · Colorectal Cancer
Australia, China
DBC-664 in Adult Patients With Solid TumorsRecruiting
NCT07705035Phase 1Updated Aug 21, 2026
Sponsor: Duboce Biopharmaceuticals, Inc.
Malignant Germ Cell Tumor · Lung Adenocarcinoma · Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma · Urothelial Carcinoma
United States
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)Recruiting
NCT07778316Phase 3Updated Aug 21, 2026
Sponsor: Amgen
Small Cell Lung Cancer
United States, China
Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.Not Yet Recruiting
NCT07778940Phase 2Updated Aug 21, 2026
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Leptomeningeal Metastasis
China
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid TumorsRecruiting
NCT05797168Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: AstraZeneca
Ovarian Cancer · Lung Adenocarcinoma · Endometrial Cancer · Lung Squamous Cell Carcinoma
United States, Australia, Canada, China, Germany +7 more
A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3Active Not Recruiting
NCT04429087Phase 1Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3
United States, Germany, Japan, Spain
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2Completed
NCT06384417NAUpdated Aug 21, 2026
Sponsor: Milton S. Hershey Medical Center
Breast Cancer · Lung Cancer · Genito-Urinary Cancer · Colorectal Cancer
United States
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Recruiting
NCT06623422Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +26 more
Clinical Genetics Branch Eligibility Screening SurveyNot Yet Recruiting
NCT07005297N/AUpdated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Melanoma · Li-Fraumeni Syndrome · Pulmonary Blastoma · Chordoma
United States
A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine CancerRecruiting
NCT05963867Phase 1Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma (SCLC) · Neuroendocrine Neoplasms
Netherlands
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)Recruiting
NCT06077760Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +28 more
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive Not Recruiting
NCT04147494EARLY_Phase 1Updated Aug 21, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Breast Carcinoma · Colon Carcinoma · Esophageal Carcinoma · Gastric Carcinoma
United States
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerRecruiting
NCT07365241Phase 3Updated Aug 21, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Austria, Germany, Greece, Japan +2 more

Previous page Next page